![Yang Lu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yang Lu
Chief Executive Officer at
ADLAI NORTYE LTD.
Net worth: 204 M $ as of 31/05/2026
Profile
Yang Lu is the founder of Adlai Nortye Ltd., where he currently serves as the Chairman & Chief Executive Officer.
He founded the company in 2018.
Mr. Lu previously worked as the Managing Director at Sinopep-Allsino Bio Pharmaceutical Co., Ltd. from 2004 to 2006.
Mr. Lu holds an MBA from China Europe International Business School, which he obtained in 2012.
He also completed his undergraduate studies at Xiamen University in 2002.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/04/2026 | 1,69,90,000 ( 100% ) | 203 M $ | 31/05/2026 | |
ADLAI NORTYE LTD. 0.32% | 13/05/2026 | 2,99,970 ( 0.32% ) | 1 M $ | 31/05/2026 |
Yang Lu active positions
| Companies | Position | Start |
|---|---|---|
| ADLAI NORTYE LTD. | Chief Executive Officer | 09/05/2018 |
Former positions of Yang Lu
| Companies | Position | End |
|---|---|---|
| JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. | Chief Executive Officer | - |
Training of Yang Lu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
99
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
China Europe International Business School
 China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xiamen University
 Xiamen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinopep-Allsino Bio Pharmaceutical Co., Ltd.
 Sinopep-Allsino Bio Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development, production and sale of peptide and small molecule chemical drugs | Health Technology |
Adlai Nortye Ltd.
 Adlai Nortye Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceuticals for cancer immunotherapy | Commercial Services |
- Stock Market
- Insiders
- Yang Lu
